Related Experiment Video
Updated: Jan 13, 2026
Antigenic Liposomes for Generation of Disease-specific Antibodies
Published on: October 25, 2018
Omalizumab for food allergy
1Division of Pediatric Allergy, Immunology and Rheumatology, Department of Pediatrics, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
Purpose Of Review:
Omalizumab was approved by the U.S. Food and Drug Administration (FDA) to reduce allergic reactions from accidental exposures to food allergens in 2024. This review examines the current state of play including the most relevant studies supporting this approval and ongoing research regarding the use of omalizumab for food Allergy.
Recent Findings:
The OUtMATCH trial demonstrated omalizumab's effectiveness in increasing the reaction threshold to multiple foods in patients with multiple food allergy. New evidence from stage 3 of OUtMATCH suggests that omalizumab can further allow dietary consumption of allergenic foods. Ongoing studies are evaluating omalizumab's role compared to oral immunotherapy (OIT) and in combination with OIT.
Summary:
Omalizumab represents an important treatment option for patients and families affected by food allergy. Significant progress has been made in understanding the drug's effects as a monotherapy and as an adjunct to OIT. As new evidence continues to emerge, the optimal use of omalizumab in managing food allergy will be further clarified.
Related Concept Videos
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
01:19Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
01:27Allergic Drug Reactions
02:06Allergic Reactions
01:20Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
01:24Antiasthma Drugs: Methylxanthines
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...